Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Efficacy of BMN 110 in Subjects With Mucopolysaccharidosis IVA [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study evaluating safety, tolerability and efficacy of BMN-110 in people with Mucopolysaccharidosis type IVA (Morquio A) with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucopolysaccharidosis Type Iva

Drugs mentioned

• BMN 110

Snippet

Sponsor: BioMarin Pharmaceutical | Conditions: MPS IV A | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-06-30